These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 24481285

  • 1. Acid-labile subunit levels and the association with response to growth hormone treatment in short children born small for gestational age.
    Renes JS, van Doorn J, Breukhoven PE, Lem AJ, de Ridder MA, Hokken-Koelega AC.
    Horm Res Paediatr; 2014; 81(2):126-32. PubMed ID: 24481285
    [Abstract] [Full Text] [Related]

  • 2. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [Abstract] [Full Text] [Related]

  • 3. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Nov; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 4. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM, van Doorn J, Mulder PG, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [Abstract] [Full Text] [Related]

  • 5. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC, van Pareren Y, Sas T, Arends N.
    Horm Res; 2003 Aug; 60 Suppl 3():113-4. PubMed ID: 14671407
    [Abstract] [Full Text] [Related]

  • 6. Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States.
    Rapaport R, Saenger P, Wajnrajch MP, Pfizer SGA Collaborative Study Group.
    J Pediatr Endocrinol Metab; 2008 May; 21(5):411-22. PubMed ID: 18655522
    [Abstract] [Full Text] [Related]

  • 7. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
    de Ridder MA, Stijnen T, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
    [Abstract] [Full Text] [Related]

  • 8. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
    Garcia RA, Longui CA, Kochi C, Arruda M, Faria CD, Calliari LE, Monte O, Pachi PR, Saenger P.
    Horm Res; 2009 Feb; 72(5):275-80. PubMed ID: 19844113
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Bjarnason R, Rosberg S, Carlsson LM, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [Abstract] [Full Text] [Related]

  • 10. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [Abstract] [Full Text] [Related]

  • 11. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW, Willemsen RH, van der Kaay DC, van Dijk M, Visser TJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
    [Abstract] [Full Text] [Related]

  • 12. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M, Dahlgren J, Bjarnason R, Rosberg S, Carlsson LM, Carlsson B, Albertsson-Wikland K.
    Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
    [Abstract] [Full Text] [Related]

  • 13. Children born small-for-gestational age: postnatal growth and hormonal status.
    Albertsson-Wikland K, Boguszewski M, Karlberg J.
    Horm Res; 1998 Oct; 49 Suppl 2():7-13. PubMed ID: 9730665
    [Abstract] [Full Text] [Related]

  • 14. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
    van der Kaay DC, Hendriks AE, Ester WA, Leunissen RW, Willemsen RH, de Kort SW, Paquette JR, Hokken-Koelega AC, Deal CL.
    Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
    [Abstract] [Full Text] [Related]

  • 15. Subclassification of small for gestational age children with persistent short stature: growth patterns and response to GH treatment.
    Ester W, Bannink E, van Dijk M, Willemsen R, van der Kaay D, de Ridder M, Hokken-Koelega A.
    Horm Res; 2008 Jun; 69(2):89-98. PubMed ID: 18059089
    [Abstract] [Full Text] [Related]

  • 16. Methylphenidate and the response to growth hormone treatment in short children born small for gestational age.
    Renes JS, de Ridder MA, Breukhoven PE, Lem AJ, Hokken-Koelega AC.
    PLoS One; 2012 Jun; 7(12):e53164. PubMed ID: 23300884
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 18. Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?
    de Kort SW, Willemsen RH, van der Kaay DC, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):582-7. PubMed ID: 19067725
    [Abstract] [Full Text] [Related]

  • 19. The somatotropic axis in short children born small for gestational age: relation to insulin resistance.
    Woods KA, van Helvoirt M, Ong KK, Mohn A, Levy J, de Zegher F, Dunger DB.
    Pediatr Res; 2002 Jan; 51(1):76-80. PubMed ID: 11756643
    [Abstract] [Full Text] [Related]

  • 20. IGF-I-IGFBP-3-acid-labile subunit (ALS) complex in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH).
    Völkl TM, Rauh M, Schöfl C, Dörr HG.
    Growth Horm IGF Res; 2011 Aug; 21(4):191-8. PubMed ID: 21636299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.